Your Article Summary
See Latest ArticlesMatrix metalloprotease regulation of neuropathic pain
Trends in Pharmacological Sciences, 07/01/09
Ji RR et al. - This recent study has shown that neuropathic pain development in the early and late phase requires MMP-9 and MMP-2, respectively. Inhibition of MMP-9 or MMP-2 might provide a new strategy for the prevention and treatment of neuropathic pain.
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Modafinil for multiple sclerosis fatigue: Does it work?
Clinical Neurology and Neurosurgery, 12/17/09
Valproate-Induced Hyperammonemic Encephalopathy and Normal Liver Functions: Possible Synergism With Topiramate
Clinical Neuropharmacology, 12/17/09
Neuroleptic Malignant Syndrome or a Statin Drug Reaction? A Case Report
Clinical Neuropharmacology, 12/17/09
Today in Pain Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
Recurrences, vaccinations and long-term symptoms in GBS and CIDP
Journal of the Peripheral Nervous System, 12/17/09
Neuropathic pain is associated with increased nodal persistent Na+ currents in human diabetic neuropathy
Journal of the Peripheral Nervous System, 12/17/09
Is botulinum toxin useful in treating headache? No
Current Treatment Options in Neurology, 12/17/09